Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy

Biophysical Journal

Volumn 75, Issue 6, 1998, Pages 3023-3030

  Roopnarine, Osha ^a   Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COMPLEMENTARY DNA; MYOSIN;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BINDING SITE; ENZYME ASSAY; FAMILIAL DISEASE; GENE MUTATION; HYPERTROPHIC CARDIOMYOPATHY; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PROTEIN PURIFICATION;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0031794853     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(98)77743-4     Document Type: Article

References (53)

1. Becker, K. D., K. R. Gottshall, R. Hickey, J. C. Perriard, and K. Chien. 1997. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly. J. Cell Biol. 137:131-140.
2. Bonne, G., L. Carrier, J. Bercovici, C. Cruaud, P. Richard, B. Hainque, M. Gautel., S. Labeit, M. James, J. Weissenbach, H. Vosberg, M. Fiszman, M. Komajda, and K. Schwartz. 1995. A splice acceptor site mutation in the cardiac myosin binding protein C gene is associated with familial hypertrophic cardiomyopathy. Nature Genet. 11:438-440.
3. Cuda, G., L. Fananapazir, W. S. Zhu, J. R. Sellers, and N. D. Epstein. 1993a. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. J. Clin. Invest. 91:2861-2865.
4. Cuda, G., J. R. Sellers, N. D. Epstein, and L. Fananapazir. 1993b. In vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. Circulation. 88:I-343.
5. Dausse, E., M. Komajda, L. Fetler, O. Dubourg, C. Dufour, L. Carrier, C. Wisnewsky, J. Bercovic, C. Hengstenberg, S. al-Mahdawi, R. Isnard, A. Hagege, J. Bouhour, M. Desnos, J. Beckman, J. Wessenbach, K. Schwartz, and P. J. Guicheney. 1993. Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene. J. Clin. Invest. 92: 2807-2813.
6. Dausse, E., and K. Schwartz. 1993. Genetic heterogeneity of familial hypertrophic cardiomyopathy. Neuromuscul. Disord. 3:483-486.
7. Davies, M. J. 1984. The current status of myocardial disarray in hypertrophic cardiomyopathy. Br. Heart. J. 51:361-366.
8. Epstein, N. D., G. M. Cohn, F. Cyran, and L. Fananapazir. 1992. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A. 908LeuVal mutation and a 403ArgGln mutation. Circulation. 86: 345-352.
9. Fananapazir, L., and N. D. Epstein. 1994. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation. 89:22-32.
10. -. Biochemistry. 34:8960-8972.
11. Fujita, H., S. Sugiura, S. Momomura, M. Omata, H. Sugi, and K. Sutoh. 1997. Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. J. Clin. Invest. 99:1010-1015.
12. Geisterfer-Lowrance, A. A., M. Christe, D. A. Conner, J. S. Ingwall, F. J. Schoen, C. E. Seidman, and J. G. Seidman. 1996. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:731-734.
13. Geisterfer-Lowrance, A. A. T., S. Kass, G. Tanigawa, H. P. Vosbert, W. McKenna, W., J. G. Seidman, and C. E. Seidman. 1990. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain missense mutation. Cell. 62:999-1006.
14. Kimura, A., H. Harada, J. E. Park, H. Nishi, M. Satoh, M. Takahashi, S. Hiroi, T. Sasaoka, N. Ohbuchi, T. Nakamura, T. Koyanagi, T. H. Hwang, J. A., Choo, K. S. Chung, A. Hasegawa, R. Nagai, O. Okazaki, H. Nakamura, M, Matsuzaki, T. Sakamoto, H. Toshima, Y. Koga, T. Imaizumi, and T. Sasazuki. 1997. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nature Genet. 16: 379-382.
15. Kraulis, P. J. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:946-950.
16. Lankford, E. B., N. D. Epstein, L. Fananapazir, and H. L. Sweeney. 1996. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Clin. Invest. 95:1409-1414.
17. Lanzetta, P. A., L. Alvarez, P. S. Reinach, and O. A. Candia. 1979. An improved assay for nanomole amounts of inorganic phosphate. Anal. Biochem. 100:95-97.
18. Lauer, B., N. V. Thiem, and B. Swynghedauw. 1989. ATPase activity of the cross-linked complex between cardiac myosin subfragment 1 and actin in several models of chronic overloading. Circ. Res. 64: 1106-1115.
19. L'Ecuyer, T. J., and A. B. Fulton. 1993. Specific and quantitative immunoprecipitation of tropomyosin and other cytoskeletal proteins by magnetic separation. Biotechniques. 4:436-441.
20. Marian, A. J., A. Mares, D. P. Kelly, Q. T., Yu, A. B. Abchee, R. Hill, and R. Roberts. 1995a. Sudden death in hypertrophic cardiomyopathy. Variability in phenotype expression of β-myosin heavy chain mutations. Eur. Heart J. 16:368-376.
21. Marian, A. J., Q. T. Yu, D. L. Mann, F. L. Graham, and R. Roberts. 1995b. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ. Res. 77: 98-106.
22. Marian, A. J., Q. T. Yu, A. Mares, Jr., R. Hill, R. Roberts, and M. B. Perryman. 1992. Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J. Clin. Invest. 90:2156-2165.
23. Maron, B. J., R. O. Bonow, R. O. Cannon, M. B. Leon, and S. E. Epstein. 1987. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N. Engl. J. Med 316:780-789.
24. Maron, B. J., W. C. Roberts, J. E. Edwards, H. A. McAllister, D. D. Foley, and S. E. Epstein. 1978. Sudden death in patients with hypertrophic cardiomyopathy. Characterization of 26 patients without functional limitation. Am. J. Cardiol. 41:803-810.
25. Maron, B. J., W. C. Roberts, and S. E. Epstein. 1986. Causes of sudden death in competitive athletes. J. Am. Coll. Cardiol. 7:204-214.
26. McNally, E. M., M. Bravo-Zehnder, and L. A. Leinwand. 1991. Identification of sequences necessary for the association of cardiac myosin subunits. J. Cell. Biol. 113:585-590.
27. Milligan, R. A. 1996. Protein-protein interactions in the rigor actomyosin complex. Proc. Natl. Acad. Sci. USA. 93:21-26.
28. Poetter, K., H. Jiang, S. Hassanzadeh, S. R. Master, A. Chang, M. C. Dalakas, I. Rayment, J. R. Sellers, L. Fananapazir, and N. D. Epstein, 1996. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genet. 13:63-69.
29. Posen, B. M., J. C. Moolman, V. A. Corfield, and P. A. Brink. 1995. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac β myosin heavy chain gene mutations. Br. Heart J. 74:40-46.
30. Rayment, I., H. M. Holden, J. R. Sellers, L. Fananapazir, and N. D. Epstein. 1995. Structural interpretation of the mutations in β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. USA. 92:3864-3868.
31. Rayment, I., H. M. Holden, M. Whittaker, C. B. Yohn, M. Lorenz, K. C. Holmes, and R. A. Milligan. 1993. Structure of the actin-myosin complex and its implications for muscle contraction. Science. 261:58-65.
32. Rayment, I., C. Smith, and R. Yount. 1996. The active site of myosin. Annu. Rev. Physiol. 58:671-702.
33. Roopnarine, O., and L. A. Leinwand. 1996. Expression and characterization of rat cardiac α and β myosin subfragment-1 in mammalian cells. Biophys. J. 70:A172.
34. Roopnarine, O., and L. A. Leinwand. 1997. Kinetic characterization of myosin mutations that cause familial hypertrophic cardiomyopathy. Biophys. J. 72:A17.
35. Sata, M., and M. Ikebe. 1996. Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. J. Clin. Invest. 98:2866-2873.
36. Schroder, R. R., D. J. Manstein, W. Jahn, H. Holden, I. Rayment, K. C. Holmes, and J. A. Spudich. 1993. Three-dimensional atomic model of F-actin decorated with Dictyostelium myosin S1. Nature. 364:171-174.
37. Smith, C. A., and I. Rayment. 1996. X-ray structure of the magnesium(II)-pyrophosphate complex of the truncated head of Dictyostelium discoidium myosin to 2.7 Å resolution. Biophys. J. 70:1590-1602.
38. Solomon, S. D., A. A. T. Geisterfer-Lowrance, H. P. Vosberg, G. Hiller, J. A. Jarcho, C. C. Morton, W. O. McBride, A. L. Mitchell, A. E. Bale, W. J. McKenna, J. G. Seidman, and C. E. Seidman. 1990. A locus for familial hypertrophic cardiomyopathy is closely linked to the cardiac myosin heavy chain genes, CRI-L436, and CRI-L329 on chromosome 14 at q11-q12. Am. J. Hum. Genet. 47:389-394.
39. Straceski, A. J., A. A. T. Geisterfer-Lowrance, C. E. Seidman, J. G. Seidman, and L. A. Leinwand. 1994. Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopapthy. Proc. Natl. Acad. Sci. USA. 91:589-593.
40. Sweeney, H. L., A. J. Straceski, L. A. Leinwand, B. A. Tikunov, and L. Faust. 1994. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J. Biol. Chem. 269:1603-1605.
41. Thedinga, E., W. J. Mckenna, and B. Brenner. 1996. Search for functional defects resulting from the 606Val-Met mutation in the β-MHC gene associated with HCM. Biophys. J. 70:A41.
42. Thierfelder, L., H. Watkins, C. MacRae, R. Lamas, W. McKenna, H. P. Vosberg, J. G. Seidman, and C. E. Seidman. 1994. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 77:701-712.
43. Thomas, D. D., J. C. Seidel, and J. Gergely. 1979. Rotational dynamics of spin-labeled F-actin in the sub-millisecond time range. J. Mol. Biol. 32:257-273.
44. Vale, R. H. 1996. Switches, latches, and amplifiers: common themes of G proteins and molecular markers. J. Cell Biol. 135:291-302.
45. Vikstrom, K. L., S. M. Factor, and L. A. Leinwand. 1996. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol. Med. 2:556-567.
46. Vikstrom, K. L., and L. A. Leinwand. 1996. Contractile protein mutations and heart disease. Curr. Opin. Cell Biol. 8:97-105.
47. Vikstrom, K. L., A. S. Rovner, C. G., Saez, M. Bravo-Zehnder, A. J. Straceski, and L. A. Leinwand. 1993. Sarcomeric myosin heavy chain expressed in nonmuscle cells forms thick filaments in the presence of substoichiometric amounts of light chains. Cell Motil. Cytol. 26: 192-204.
48. Vybiral, T., P. R. Deitiker, R. Roberts, and H. F. Epstein. 1992. Accumulation and assembly of myosin in hypertrophic cardiomyopathy with the 403 Arg to Gln beta-myosin heavy chain mutation. Circ. Res. 71: 1404-1409.
49. Watkins, H., D. Conner, T. Thierfelder, J. A. Jarcho, C. MacRae, W. J. McKenna, B. J. Maron, J. G. Seidman, and C. E. Seidman. 1995a. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet. 11: 434-437.
50. Watkins, H., W. J. McKenna, L. Thierfelder, H. J. Suk, R. Anan, A. O'Donoghue, P. Spirito, A. Matsumori, C. S. Moravec, J. G. Seidman, and C. E. Seidman. 1995b. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332:1058-1064.
51. Watkins, H., A. Rosenzweig, D. S. Hwang, T. Levi, W. McKenna, C. E. Seidman, and J. G. Seidman. 1992. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N. Engl. J. Med. 326:1108-1114.
52. Watkins, H., J. G. Seidman, and C. E. Seidman. 1995c. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum. Mol. Genet. 4:1721-1727.
53. Watkins, H., L. Thierfelder, A. Anan, J. A. Jarcho, A. Matsumori, W. McKenna, J. G. Seidman, and C. E. Seidman. 1993. Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy. Am. J. Hum. Genet 53:1180-1185.